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Anhedonia (defined as the inability to experience pleasure) is a symptom that is
difficult to treat in patients with Major Depressive Disorder (MDD). Prior research
suggests that the left dorsolateral prefrontal cortex (DLPFC) is a major underlying
mechanism in the pathophysiology of depression. Therefore, we investigated whether
repetitive transcranial magnetic stimulation (rTMS) treatment to the left DLPFC would
predict a reduction in one facet of anhedonia symptomatology—namely, reward derived
from positive social stimuli (i.e., smiling human faces)—in 26 depressed adults. The
results revealed no significant effects of rTMS treatment on either accuracy or speeded
reaction time during a novel behavioral task that involved identifying positive emotion in
human faces. This suggests that although rTMS may be an innovative technique to
reduce depressive symptoms in adults with MDD overall, its efficacy may not hinge on a
meaningful reduction in this particular aspect of anhedonia.
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1 INTRODUCTION
Depression is a common mental disorder and is the leading cause of disability
worldwide, affecting more than 300 million people of all ages (WHO, 2018). Anhedonia,
defined as the reduced capacity to experience pleasure, is a symptom present in
several different types of psychiatric disorders and has been recognized as a core
feature of depression (Romney & Candido, 2011; Leventhal et al., 2006). In fact,
anhedonia has been hypothesized to be a prodrome, and thus a predictor, for the later
development of depressive disorder across multiple age groups (Loas, 1996;
Gudmundsen et al., 2018). Anhedonia is a particularly difficult symptom to treat, as prior
evidence suggests that first-line pharmacotherapies, such as selective serotonin
reuptake inhibitors (SSRIs), do not adequately address hedonic deficits in depression
(Treadway & Zald, 2011).
The prevalence of anhedonia in depression may be driven by at least two factors.
First, individuals with depression are generally biased toward processing negative
stimuli faster and more efficiently than positive stimuli (Beck, 1972). Specifically, Beck’s
Cognitive Triad theory postulates that depressed individuals engage in negativelybiased thinking that influences the way they view themselves, the world, and their
future. Their lived experiences and schemas become filtered by their negative
automatic cognitions, which affects the way they attend to and process information in
their environment (Beck, 1967). It is thought that the negative schemas and attitudes
held by individuals who are currently depressed and/or are susceptible to depression
are maintained by activation of the cognitive triad, which can result in myriad depression
symptoms, such as fatigue, amotivation, and anhedonia (Leahy & Dowd, 2002).
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However, it is also possible that a more direct deficit in positive affectivity itself may
also contribute to the emergence of anhedonia. For example, it may not be just a
matter of not attending as well to positive stimuli, but a deficit in the actual interpretation
of hedonic information may also exist. This possibility is based on a growing literature
that suggests that individuals with depression do not always derive the same hedonic
value from positive stimuli as healthy controls, even when their general attention is
focused appropriately.
Previous research investigating anhedonia in depression has shown significantly
reduced responsiveness to, and appraisal of, reward values (Gorwood, 2008). For
example, a neuroimaging study conducted by Heller et al. (2009) found that depressed
individuals demonstrated a reduction in activation in the nucleus accumbens (NAcc),
which, along with the fronto-striatal network, is implicated in reward appraisal and
motivation, over time during a positive affect evoking task compared to controls. These
findings suggest that individuals with depression are unable to adequately sustain a
response toward positive stimuli; this anomaly in brain activity patterns may represent
an actual loss in reward value across time. This may interfere with depressed
individuals’ ability to sustain positive mood across time in everyday life, making it more
probable—given their negative schemas and hypersensitivity to negative stimuli—that a
negative mood can take hold and be maintained.
Thus, anhedonia not only encompasses a reduction in the capacity to subjectively
experience pleasure from activities that most people find enjoyable (e.g., a good meal
or a good book), but also is characterized by an inability to sustain neural activity in
regions that are thought to support positive affect over time (Tomarken and Keener,
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1998). In another neuroimaging study, Keller et al. (2013) assessed trait anhedonia via
a questionnaire in healthy adults without prior history of Axis I diagnoses and had them
rate the pleasantness of various pieces of music. Individuals who initially endorsed
higher trait anhedonia levels rated the music pieces as less pleasant; greater trait
anhedonia was also associated with reduced activity in various brain regions that are
integral to reward processing, such as the NAcc.
Together, these findings suggest that anhedonia in depressed patients involves
neural networks that are involved in: a) negative schemas, b) general reward
processing, and c) the ability to sustain a neural response over time following positive
stimulation, with disruptions in the underlying fronto-striatal networks resulting in
difficulties in responding appropriately to positive stimuli.
Anhedonia also has a very social component, in that individuals who are anhedonic
may (or may not) show deficits in the number and quality of their positive relationships.
Indeed, there is a subtype of anhedonia termed “social anhedonia” that is characterized
by a reduced ability to derive pleasure from social situations. However, given that the
broader construct of anhedonia, which includes both social and non-social aspects, has
not yet been investigated using repetitive transcranial magnetic stimulation (rTMS), one
aim of the current work was to determine how anhedonia proper (encompassing both
social and non-social aspects of the construct), may relate to a particular aspect of
social anhedonia (i.e., response to smiling faces) that we chose to measure using a
facial emotion recognition task.
The human face conveys detailed information about the emotional state of other
people, and we interpret others’ emotions in part by analyzing facial displays at both
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conscious and unconscious levels. Here, our interest was in how depressed people
read the happy facial displays of other people. We conceptualize this activity—
subjective interpretation of pleasure on the face of another human being—as one
narrow proxy for how people may take in and experience joy themselves. Indeed,
researchers have already identified an association between the ability to accurately
read happy facial expressions and the experience of anhedonia (broadly construed).
For example, the presence of anhedonia has been linked to a slowed ability to
accurately identify positive facial emotions (Vrijen et al., 2016), which may, in turn,
relate to a reduced subjective experience of positive emotion in response to the joy of
another human being (generally a rewarding event under normal circumstances).
Furthermore, there is a probable relationship between the ability to experience
pleasure as a result of seeing a smiling face and the ability to discriminate among
positive faces eliciting varying intensities. In fact, although it may be easy to read a
frank smile and derive pleasure from it, it may be more difficult for individuals to read
and subjectively experience pleasure in response to a slight smile. Here, it is
hypothesized that individuals who are genetically or biologically prone to accurately
perceive subtle positive emotion may be less vulnerable to anhedonic symptoms,
whereas individuals who are poor at this particular ability may be more likely to
experience anhedonia.
Efforts to combat the deleterious effects of depression have primarily focused on
how to decrease sadness. Furthermore, the use of antidepressant medications,
including SSRIs, has resulted in inconsistent findings, and these medications often fail
to address anhedonic symptoms and amotivation in patients with MDD (Nutt et al.,
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2007; Shelton & Tomarken, 2001). Behavioral Activation (BA), a psychotherapeutic
approach that aims to increase engagement in adaptive activities and to solve problems
that limit an individual’s access to rewards, has been commonly used to treat
depression symptoms overall; yet, the research in the use of BA as a therapeutic
method to ameliorate symptoms of anhedonia is inconsistent (Strauss, 2013). Given
inconsistencies in the literature regarding the efficacy of currently available treatments
for depression, there is an increasing demand to identify and test the efficacy of
alternative treatment modalities that may prove to be more efficient in addressing
specific symptoms such as anhedonia. rTMS represents a novel treatment that could
potentially address these concerns.
1.1

Depression and Anhedonia
A diagnosis of MDD, as stated in the Diagnostic and Statistical Manual of Mental

Disorders, Fifth Edition (DSM-5), requires the presence of either a depressed mood or a
loss of interest/pleasure that contributes to a change from prior functioning (DSM-5,
2013). Previous studies have estimated that more than two-thirds of all individuals
diagnosed with MDD experience clinically significant levels of anhedonia (Buchwald &
Rudick-Davis, 1993). The occurrence and manifestation of anhedonia in depressed
individuals can be affected by a variety of factors such as race, ethnicity, and
socioeconomic status (SES); Liu and Tronick (2014) found a greater likelihood for
Hispanic, African-American, and Asian/Pacific Islander women to endorse symptoms of
postpartum anhedonia than White women. However, after accounting for SES,
postpartum anhedonia was more likely to be reported by Asian/Pacific Islanders than
members of any other racial group (Liu & Tronick, 2014).
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The cognitive model of depression proposed by Aaron Beck (1979) is grounded in
the concept of the “cognitive triad,” in which the depressed individual tends to have
negative views of him/herself, to interpret ongoing experiences in a negative way, and
to have negative views about the future. Consistent with these theories, depressed
individuals tend to exhibit a predilection to attend to, remember, and process negative
stimuli in their environment more efficiently than positive stimuli that contradict their
schemas (Blaney, 1986; Clark & Teasdale, 1982; Kuiper & Derry, 1982).In Disner et
al.’s (2011) cognitive model of depression (Figure 1), depressed self-referential
schemas in a vulnerable individual trigger biased attention, biased processing, and
biased memory of internal and external stimuli. The depressed individual filters
perceived information in a manner that over-represents the schema-consistent elements
of the experience. This biased focus toward schema-related elements in the
environment, in turn, maintains depressive symptoms. The presence of depressive
symptoms continues to strengthen and validate the vulnerable individual’s negative
schema, thus reinforcing the cycle of biased processing of perceived experiences.
Importantly, the depressive cognitions and negatively-biased worldviews central
to Beck’s cognitive model of depression are often accompanied by symptoms of
anhedonia and thoughts of hopelessness (Beck et al., 2003). Though models have
varied across time, the most current models suggest that a complex neural circuit
mediates the processing of hedonic information and emotional stimuli. Indeed, reduced
activity in many areas of the prefrontal cortex have been implicated in anhedonia, with
abnormal activity observed in regions such as the dorsolateral prefrontal cortex
(DLPFC), ventromedial prefrontal cortex (VMPFC), and orbitofrontal cortex (OFC) (Der-

7
Avakian & Markou, 2011). The reward-processing neural circuitry recruits inputs and
outputs from both cortical (i.e., VMPFC, DLFC) and subcortical structures (i.e., anterior
cingulate cortex (ACC), NAcc), and disruptions and abnormal activity in these neural
circuits can result in anhedonia-like symptoms and hedonic deficits (Der-Avakian &
Markou, 2011).
Addressing negative biases and cognitions alone does not generally bring positive
emotions online. Increasing research suggests that treatment of depression should
involve not only dismantling negative schemas and the cognitive triad, but also directly
intervening to modulate the positive affect system in the brain. These different systems
can be activated separately, and currently available treatments may be more or less
efficacious for one or the other aspect of emotionality. For example, previous research
has already identified associations among anhedonia, trait emotionality (i.e., positive
and negative mood), and social functioning. Blanchard et al. (1998) used multiple
questionnaires to assess anhedonia, positive and negative affectivity, and overall social
functioning in individuals with schizophrenia. They found a negative correlation
between anhedonia and trait positive affect. Additionally, individuals with greater
anhedonia reported greater negative affect and poorer social functioning than controls
(Blanchard et al., 1998). Given that anhedonia is considered a trans-diagnostic
symptom, it offers a meaningful avenue for research in MDD samples as well.
Another study used a mediation analysis to demonstrate a link between social
anhedonia and social functioning by assessing activity in brain regions associated with
Theory of Mind (ToM), or the ability to explain and predict other people’s mental states.
Individuals who experienced greater social anhedonia exhibited hypoactivation in the
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medial prefrontal cortex and impaired activity in the ToM neural circuitry. These
anomalies likely contributed to a hampered ability to understand and reason about the
mental states of others in everyday life (Dodell-Feder et al., 2014). These studies
highlight the negative effects of anhedonia, which not only contribute to a decreased
response to pleasurable rewards, but also negatively impact people’s ability to function
in social settings.

Figure 1.1. Information processing in the cognitive model of depression proposed by
Disner et al. (2011)
1.2

Facial Emotion Recognition
An important bottom-up process that plays a crucial role in vicarious emotional

processing is the ability to detect emotional valence in facial expressions. Facial
expressions help convey emotionally salient information about an individual’s internal
state; they also help us communicate emotions to others, which facilitates appropriate
social behavior (Knutson, 1996). Although the interpretations of different facial
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expressions may vary across cultural groups, the detection of emotions from facial
expressions is a universal skill observed among members of both literate and illiterate
cultures (Ekman & Friesen, 1971; Ekman et al., 1987).
The ability to recognize, decode, and discriminate among emotional facial
expressions develops with age. Whereas correct identification of happiness, sadness,
and anger from facial expressions develops early in childhood, the ability to identify
facial expressions of fear, disgust, and surprise continues to develop over the course of
late childhood and adolescence (Lawrence, Campbell, & Skuse, 2015). The ability to
accurately recognize facial expressions predicts likeability among peers and social
competence through later childhood and adolescence (Izard et al., 2001; Miller et al.,
2005; Mostow, Izard, Fine, & Trentacosta, 2002). Individuals interpret human faces to
avoid conflict, predict the attitudes of other people, and to monitor and appropriately
respond to social interactions with others (Hess, Kappas, & Scherer, 1988; Salovey &
Mayer, 1990). This process may be disrupted in the context of depression. In particular,
depressed individuals, with their negatively biased internal schema, who display a
predisposition toward heightened processing of negative stimuli and reduced
processing of positive stimuli in their environment, may also exhibit a response bias
when attending to faces eliciting negative emotions compared to faces that display
positive emotions.
Indeed, individuals with MDD show difficulties in the efficient and accurate
recognition of both positive and negative emotions in faces. Specifically, Surguladze et
al. (2004) showed that—compared with healthy volunteers—depressed patients
demonstrated a bias away from the accurate identification of happy and positive
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expressions. Similarly, Demenescu et al. (2010) found, in a meta-analytic study, that
patients with MDD exhibited significant biases in overall emotional facial identification.
Another study found that depressed patients, compared to healthy controls, were slower
and more inaccurate at recognizing neutral faces; they also reported a higher incidence
of sad responses to neutral faces. These findings further highlight the tendency among
depressed individuals to misinterpret neutral emotions as negative (Leppanen et al.,
2004; Gur et al., 1992). Further, Joorman and Gotlib (2006) found that individuals with
MDD required significantly greater intensity of positive emotion to accurately identify
happy faces compared to faces that displayed emotions such as fear and sadness,
indicating reduced reward responsiveness. Taken together, the evidence suggests that
individuals with MDD struggle to identify emotions from facial stimuli accurately.
Differences in the speeded identification of emotion from facial stimuli have also
been identified between patients with MDD and healthy controls. In one recent
prospective study, reduced speed in identifying happy faces relative to sad faces
prospectively predicted the onset of depressive disorder and symptoms of anhedonia in
adolescence (Vrijen et al., 2016). This finding adds credence to the hypothesis that
individuals are faster at identifying stimuli that are congruent with their emotional state in
the moment; therefore, individuals who are at risk for MDD, who display symptoms of
anhedonia, or who are currently diagnosed with MDD all are likely to react faster to
negative stimuli (sad faces) than to positive stimuli (happy faces). However, current
research looking at the speeded responses to facial stimuli is scarce, and what remains
to be more fully elucidated is whether response speed varies across different intensities
of positive stimuli.
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Given the importance of speeded processing of affective information in the ability
to respond appropriately to environmental and social demands, depressed individuals
who exhibit a bias in speeded processing of positive stimuli of various intensities may
also produce more errors in emotion recognition, which could negatively impact their
ability to function normally in social contexts in everyday life (Gross, 1998; Gollan et al.,
2008). Research focused on the speeded identification of positive facial expression in
patients with MDD is sparse. Further research is warranted to help us better understand
mechanisms that underlie identification of positive facial emotion in individuals with
MDD. This understanding could also help improve emerging treatments.
1.3

Repetitive Transcranial Magnetic Stimulation
Relapse in treated individuals with MDD, even following acute interventions such

as electroconvulsive therapy (ECT), is common (Coppen et al., 1981; Grunhaus,
Dolberg, & Lustig, 1995). To address this problem, clinicians and researchers have
begun to explore new pharmacologic and nonpharmacologic approaches, including
rTMS, to ameliorating depression (Mantovani et al., 2012). Several meta-analyses of
placebo-controlled trials have indicated that rTMS is effective in providing acute,
clinically significant antidepressant effects; further, additional studies have investigated
the safety and efficacy of TMS as an acute antidepressant form of treatment (Mantovani
et al., 2012; Moreines, McClintock & Holtzheimer, 2010).
Studies have also investigated neural mechanisms of depression and the
antidepressant effects of rTMS. For example, research has strongly implicated the
DLPFC, particularly the left DLPFC, in the pathophysiology of depression (Davidson,
2004; Taylor & Liberzon, 2007). Specifically, the lateral prefrontal cortex has been
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implicated in eudemonia (i.e. well-being; Heller et al., 2013) and anhedonia (Light et al.,
2011) during attempts to up-regulate (DLPFC) or down-regulate (ventrolateral prefrontal
cortex (VLPFC)) positive affect. It is thought that hypo-activation of the DLPFC in
particular relates to the reduced experience of positive emotions (Davidson, 2004;
Heller et al. 2013), whereas increased VLPFC activity relates to the suppression of
positive emotion often seen in depressed individuals (Light et al., 2011).
Prior research also indicates that those individuals with MDD who respond to
antidepressant treatment showed increases in activity in DLPFC pre- to post-treatment
(Taylor & Liberzon, 2007; Brody et al., 2001). Thus, because depression is associated
with a decrease in left DLPFC activity, studies have successfully used high-frequency
rTMS to induce greater cerebral blood flow in this region to induce a clinical
antidepressant effect (Nahas et al., 2001; Gross et al., 2007; Rumi et al., 2005).
Further, Avery et al. (2006) found that the clinical effects of rTMS to the left DLPFC
increased with the duration of the treatment, highlighting a linear effect between the
number of rTMS sessions and depression score reduction. Importantly, the efficacy of
rTMS to the left DLPFC may also lie in its indirect effects on other brain regions; for
example, it may initiate or enhance negative connectivity between DLPFC and the a)
subgenual cingulate (Taylor et al., 2018) and b) frontopolar prefrontal cortex (Downar &
Daskalakis, 2013). Regardless of the pathways along which it operates, we
hypothesize that rTMS targeting the left DLPFC is a promising region approach to
anhedonia reduction in depressed individuals.
Further, advancement in individualizing rTMS treatment to particular patients may
spring from specifically investigating the effectiveness of rTMS on one or more specific
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aspects of anhedonia. Given that the two key symptoms present in depression are
anhedonia and/or sad mood, determining the effectiveness of rTMS on anhedonia in
particular (versus global depression symptomatology), and a very specific aspect of
anhedonia at that—positive emotion recognition in human facial stimuli—may help
identify rTMS treatment protocols that are better or more poorly suited to target this
specific symptom. Indeed, the efficacy of rTMS varies depending on site of stimulation,
and not all patients who receive the treatment respond. Therefore, by using a novel
behavioral task to look for distinct relationships between performance on the task and
rTMS treatment response at the symptom level (rather than looking for a relationship
simply between self-reported anhedonia and response to rTMS treatment), we may
provide a means by which to ascertain whether this aspect of the disorder changes preto post- rTMS.
In the current study, individuals with MDD underwent a series of either active or
sham rTMS sessions targeting the left DLPFC and completed a novel behavioral task
that required each participant to identify various intensities of positive emotion in a
series of human faces, pre- to post-treatment. Previous studies have identified a
significant correlation between increased accuracy in recognition of happy faces and
clinical improvement after six-weeks of antidepressant medication treatment (Tranter et
al., 2009). Although multiple studies have yielded evidence of improvements in the
accurate identification of positive emotions in facial stimuli post-treatment, few studies
have examined associations between the accurate identification of varying intensities of
positive emotion and the effects of treatment on how quickly people accurately detect
happiness in human faces. Considering that depressed individuals demonstrate a
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predilection toward identifying negatively-valenced faces quickly and are typically less
accurate and slower in identifying faces that express positive emotion, successful
treatment of both of these positive and negative affective symptoms of depression may
help shift these individuals’ emotional predispositions and result in better, more accurate
interpretations of positive emotion in human faces post-treatment (Leppanen et al.,
2004; Gur et al., 1992). Additionally, as previous research has suggested that
individuals with MDD are typically faster at detecting negative faces than positive faces,
treatment with rTMS may result in faster response speeds to positive emotion in faces if
rTMS is able to influence neural mechanisms associated with positive affectivity
(Suslow & Junghanns, 2001). Given the utility of rTMS as an innovative and low-risk
technique to alleviate symptoms of depression, the proposed study aims to identify
beneficial effects of rTMS on the left DLPFC on the speed and accuracy with which
depressed people identify positive emotion in human faces, a skill that is often impaired
in anhedonic individuals and thus may serve as one behavioral marker of the symptom.
1.4

Specific Aims and Hypotheses
Despite research on the utility of rTMS as a therapeutic technique to decrease

general symptoms of depression, questions remain regarding its long-term efficacy, as
well as its effects on the perceptual biases of individuals with MDD. The current study
serves to address this issue by observing whether multiple sessions of rTMS will have
an effect on an individual’s performance on a task that requires accurate and speeded
identification of positive emotion. As rTMS has been previously shown to provide
antidepressant effects for individuals with MDD (Mantovani et al., 2012), and given that
depressed individuals tend to exhibit a negative processing bias in interpreting neutral
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faces as sad and are typically slower, less accurate, and require higher intensity happy
faces to accurately categorize human faces as happy, we hypothesized that rTMS to
the left DLPFC would impact the speed and accuracy of identification of positive
emotions in human faces. This hypothesis is based on prior literature and the idea that
individuals who are more anhedonic have two problems that may make it difficult for
them to attend to and interpret positive information in their environment: 1) a negative
processing bias, and 2) an intensity bias, such that it takes exposure to more intense
positive stimuli for them to register and interpret a conveyed positive emotion. We were
most interested the intensity bias in our investigation of rTMS to the left DLPFC.
The current study focused on a sample of adults diagnosed with MDD and used
a novel behavioral measure of positive emotional identification (i.e. the “Happy Faces”
task) to investigate the effectiveness of rTMS on this social aspect of anhedonia. The
study could have direct impacts on the fields of psychiatry, clinical neuropsychology,
and positive psychology; further, this study will contribute to the growing body of work
on the role of emotional processing in depression.
1.4.1 Specific Aim 1
Determine the effect of rTMS to the left dorsolateral prefrontal cortex on the
speeded identification of various intensities of happy emotional faces.
Hypothesis 1: Individuals in the active rTMS group would be faster in the identification
of faces, specifically to low-intensity faces on the Happy Faces Task, by post-treatment
than individuals who underwent the sham treatment.
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1.4.2 Specific Aim 2
Determine the effect of rTMS to the left dorsolateral prefrontal cortex on the
accurate identification of various intensities of happy emotional faces.
Hypothesis 1: Individuals who underwent active treatment will show statistically
significant improvement in their performance at post-treatment relative to pre-treatment
(compared to individuals in the sham group). In particular, we expected patients to
make gains in accurately identifying low intensity happy faces (relative to high intensity
happy faces, where we anticipated no gains pre-post treatment).
2

METHODS

2.1 Procedures
2.1.1 Participants
Twenty-six adults (Mage = 45.21, SD = 11.21, 63% women) were recruited for the
study. Of these adults, 97% identified themselves as non-Hispanic white; one
participant self-identified as Asian. To be enrolled, participants had to be between the
ages of 22 and 65 years, and to meet DSM-IV diagnostic criteria for MDD, as assessed
with the Mini-International Neuropsychiatric Interview (M.I.N.I.) (Sheehan et al., 1998).
In addition, they had to obtain a score of 18 or higher on the Montgomery-Asberg
Depression Rating Scale (MADRS), a 9-item questionnaire that includes questions
about sadness, inner tension, reduced sleep, an inability to feel, pessimistic and suicidal
thoughts, and concentration difficulties. Finally, participants were required to have
experienced failure of at least one antidepressant treatment at adequate dose/duration
or have failed to achieve adequate dose/duration due to intolerable side effects, and to
have been on a current stable dose of medication for at least four weeks prior to rTMS
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therapy. Medications had to be maintained on a stable dosage for one month prior to
and during the double-blinded phase. Potential participants were excluded if they
reported presence of bipolar disorder (I/II), obsessive-compulsive disorder, posttraumatic stress disorder, any psychosis, or serious suicidal ideation/behavior; previous
repetitive Transcranial Magnetic Stimulation (rTMS) treatment; previous ECT, and
contra-indications to rTMS or MRI. Table 1 shows the means and standard deviations
for age, number of medications used, and MADRS prescreen scores for each group.
Table 1
Demographics and Participant Characteristics
Active rTMS Group
Sham rTMS Group
Gender
n
12
14
% Female
75
57.1
% Male
25
42.9
Age
45.25
44.78
SD
10.88
10.71
Number of Medications
2.75
2.28
SD
1.48
1.33
MADRS Scores
24.5
21.64
SD
5.38
3.67
Range
18-33
18-25
SHAPS Scores**
31.83
35.21
SD
3.79
4.92
Range
28-38
28-43
Note: MADRS = Montgomery-Asberg Depression Rating Scale;
SHAPS = Snaith Hamilton Pleasure Scale
**Based on Franken et al. (2007), a score equal to or greater than 29 indicates clinically
significant anhedonia using the 2-standard deviation rule
2.1.2 Measures
The Montgomery-Asberg Depression Rating Scale (MADRS), a 9-item
questionnaire that includes questions about sadness, inner tension, reduced sleep, an
inability to feel, pessimistic and suicidal thoughts, and concentration difficulties. The
score range is 0-27 points, and a score at baseline on the MADRS of 18 or greater was
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required for study entry. The MADRS has been found to have high internal consistency
(Cronbach’s alpha = 0.85), construct validity, and concurrent validity relative to other
depression screeners such as the Beck Depression Inventory – II (BDI-II) and the
Hamilton Depression Scale (Kjærgaard et al., 2014; Davidson et al., 1986).
The Snaith-Hamilton Pleasure Scale (SHAPS) is a 14-item self-report scale that
assesses the respondent’s ability to feel pleasure in response to stimuli that typically
elicit positive emotions. The SHAPS covers four domains: interests/pastimes, social
interaction, sensory experience, and food/drink. The inter-item reliability for this test is
0.857 and higher scores are indicative of greater anhedonia (Snaith et al., 1995;
Nakonezny et al., 2015). Published normative data indicate that healthy controls who
are not anhedonic exhibit a mean score of 20.4 (Franken et al., 2007), whereas the
sample of confirmed depressed patients had a mean score of 34.4 (Franken et al.,
2007). Using a cut-off of two standard deviations above the mean of healthy controls to
indicate clinically significant anhedonia, these data suggest that a score of 29 or greater
indicates clinically significant anhedonia.
The Happy Faces Task is designed to ascertain levels of anhedonia (Mirabito et
al., 2019). During the task, patients are asked to look at human faces (balanced by
gender) evincing varying degrees of positive emotion. The task consists of 20 lowintensity trials and 33 high-intensity trials presented in random order, with 22 neutral
trials interspersed. When the task was developed, researchers selected stimulus faces
from the well-validated Cohn-Kanade dataset, which includes hundreds of images of
human faces expressing neutral and varying degrees of spontaneous positive emotion
(Cohn, Ziochower, Lien & Ambadar, 1999; Ambadar, Cohn & Reed, 2009). They then
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identified faces that elicited “low-intensity” positive emotions (i.e., subtle smiles) or
“high-intensity” positive emotions (i.e., frank smiles) (Mirabito et al., 2019). Specifically,
faces that showed only zygomaticus activity (facial muscles that control mouth-based
actions of smiling) were identified as low intensity, and faces that showed both
orbicularis (facial muscles that control the eyelid region) and zygomaticus activity were
identified as high intensity. Whereas some task paradigms use facial stimuli that span a
broad range of discrete emotions, the Happy Faces Task focuses simply on the
presence or absence of positive emotion of any type.
During the Happy Faces Task, participants were instructed to indicate by button
press whether any positive emotion was present on the face they were viewing in “yes”
or “no” format. Importantly, the face remained on the screen until the participant made
a response and their reaction time was recorded. Task duration was approximately 10
minutes for each participant. In a recently published study that used the Happy Faces
Task during fMRI scanning, findings yielded evidence that the Happy Faces Task is a
valid measure of consummatory anhedonia and may have clinical utility in anhedonic
populations (Mirabito et al., 2019).
2.1.3 Procedure
The protocol was a sham-controlled, randomized, double-blind study. A research
assistant conducted a psychiatric assessment (the MADRS, a MINI-Structured Clinical
Interview for DSM-IV disorders, and a psychiatric interview) with each potential
participant before study enrollment. Patients who met study inclusion criteria then
provided informed consent to take part in the full study. They then underwent an
assessment process, which included the completion of the SHAPS and the pre-
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treatment Happy Faces Task. Participants also underwent MRI scanning to identify
target locations for rTMS treatment. All patients eventually received rTMS treatment,
but at study entry, they were randomly assigned to a sham treatment or active treatment
group.
Following screening and assessment, subjects entered phase one of the study.
In this blinded phase, subjects had 20 sessions of rTMS therapy or sham treatment,
delivered on five days per week for four weeks by a licensed psychiatrist. rTMS
treatments were delivered at 10 Hz frequency at 120% of motor threshold, with 3000
pulses/session to the left DLPFC at a location determined by neuronavigation from each
participant’s initial Magnetic Resonance Imaging (MRI) session. TMS was delivered
with the NeuroStar XPLOR system in research mode. Whereas the coil in the active
rTMS group was active, the sham coil, which was identical in shape and weight to the
active coil, did not deliver any magnetic energy. A speaker on the coil gantry delivered
a 10Hz pulsed sound that mimicked acoustic characteristics of the active coil. At the
end of phase one, five taper TMS sessions over two weeks were performed for those in
the active arm and five sham taper sessions were delivered over two weeks to sham
participants (phase two). Participants from both groups completed the Happy Faces
Task at the end of their respective treatment. Subjects who received sham stimulation
had the option of receiving active TMS in the second, open-label phase of the study.
2.1.4 Analytic Plan
In order to determine the effect of rTMS to the left DLPFC on the speeded and
accurate identification of various intensities of happy emotional faces over time, we
conducted two repeated-measures ANCOVAs for each dependent variable. A repeated-
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measures ANCOVA was used given our interest in examining group differences in
performance as a function of time (pre-treatment and post-treatment) and intensity of
the happy face (i.e., high, low, neutral). In our analyses, accuracy and reaction speed
on the Happy Faces Task served as dependent variables, while group membership (i.e.,
active vs. sham treatment) was included as the independent variable.
ANCOVA, rather than ANOVA, was a preferable approach because we included
a number of covariates in our analysis. First, age and sex were included, given
evidence from epidemiological studies that these factors such as age and sex can
influence the prevalence of MDD, such that depressive symptoms are more common in
females in young adulthood and less common in patients aged 65 years (Gallo et al.,
1994; Bebbington et al., 1998; Stordal et al., 2001). Second, we included indices of
depression severity (i.e., number of medication, MADRS score) as covariates in the
analysis to control for the possibility that effects of treatment on task performance might
be attributable to baseline depression severity (Nakonezny et al, 2010). Koenig et al.
(1998) found that the number of medications taken, akin to illness severity, was
significantly related to depression severity in an elderly population. Finally, in order to
control for the possibility that effects of treatment on task performance might be
attributable to baseline subjective experience of anhedonia (which may not be an
accurate indicators of their behaviorally observed/measured anhedonia), we included
pretest SHAPS scores as an additional covariate.
We also decided to run two separate ANOVAs looking at group effects on both
dependent variables (i.e., accuracy and reaction speed) with the exclusion of these
covariates. Given the small sample size and low power in the study, we conducted
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these analyses in order to see if the exclusion of these variables would have any effect
on the statistical output.
In additional exploratory analyses, we also ran two ANCOVAs without including
the baseline levels of anhedonia (SHAPS score) as a covariate in order to increase the
statistical power of the analysis and to examine whether baseline self-reported SHAPS
scores would meaningfully affect performance on the Happy Faces Task.
Prior to conducting the main analyses, we examined the data for potential
sources of biases. First, we generated boxplots to identify outliers in the data. We
identified three univariate outliers in the dataset; we therefore winsorized the data by
replacing outliers with the next highest score that was not an outlier. We then
conducted Levene’s tests for each of the dependent variables in order to check for
assumptions of homogeneity of variances; results were not significant for any variables,
indicating that the assumption of homogeneity of variances was met. Finally, we
conducted Mauchly’s test to assess for the presence of sphericity (the variation within
the experimental conditions is roughly equal). Violation of sphericity may create a loss
of power and an inaccurate test statistic. Results of the Mauchly tests were not
significant, which indicates that data met the assumptions of sphericity.
3

RESULTS

The patients’ pre- and post-treatment performance based on group membership
on speeded reaction times (ms) and accuracy scores relative to the corresponding facial
stimuli (low-intensity, neutral, or high-intensity) are presented in Table 2.
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Table 2
Participant Performance on Reaction Speed and Accuracy to Different Intensities of
Happy Faces based on Group and Type of Facial Stimuli
Group
Active
Sham
Measure
Mean
SD
Mean
SD
Rx to low-intensity 1
2083.00
870.22
1661.63
916.78
Rx to low-intensity 2
1646.88
476.92
1354.30
386.47
Acc to low-intensity 1
13.08
3.92
12.07
4.98
Acc to low-intensity 2
13.92
4.08
12.71
4.75
Rx to high-intensity 1
1266.86
563.17
1068.12
385.49
Rx to high-intensity 2
1200.88
346.49
976.60
180.16
Acc to high-intensity 1
31.42
2.07
31.43
2.56
Acc to high-intensity 2
32.17
1.34
32.43
1.02
Rx to neutral 1
1729.68
746.87
1569.67
851.45
Rx to neutral 2
1785.17
468.71
1450.25
591.49
Acc to neutral 1
18.17
2.48
18.50
2.14
Acc to neutral 2
18.17
2.25
17.50
3.32
Note: 1 = pre; 2 = post; Rx = Reaction Time, Acc = Accuracy
3.1 Reaction Speed
As shown in Table 3, results from a repeated-measures one-way ANCOVA, with
reaction speed as the dependent variable and number of medications, age, SHAPS
scores, MADRS scores, and gender included as covariates, yielded no evidence of
statistically significant main effects of treatment group, time, or face type. The
interaction between time and group membership was also non-significant.
Results did, however, indicate a significant effect of pre-treatment SHAPS scores
on reaction speed (F(1,20) = 4.76, p = .04, ηp2 = .19). A correlation matrix presented in
Table 4 shows that pre-treatment SHAPS scores were negatively correlated with
reaction times to low intensity faces prior to treatment and neutral faces post-treatment.
In other words, contrary to our predictions, participants who endorsed higher levels of
anhedonia on the SHAPS responded faster to low intensity and neutral faces.
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Table 3
Repeated-Measures ANCOVA with Reaction Speed as the Dependent Variable
Tests of Within-Subjects Effects
Type III Sum
df
F
p
of Squares
Time
20610.49
1
.04
.85
Facial Intensity
853393.08
1
2.67
.08
Time * Group
337679.74
1
.58
.46
Tests of Between-Subjects Effects
Type III Sum
df
F
p
of Squares
Intercept
5340569.89
1
5.60
.03
Gender
185402.72
1
.19
.66
MADRS
1687844.76
1
1.77
.20
Medications
290780.49
1
.31
.59
SHAPS
450113.63
1
4.76
.04*
Group
49348.42
1
.05
.82
Error
19071053.80
20
*p < .05
Table 4
Correlation Matrix (SHAPS and Rx)
Correlation Matrix
Measure
Rx to low intensity 1
Pearson Correlation
Sig. (2-tailed)
Rx to low intensity 2
Pearson Correlation
Sig. (2-tailed)
Rx to neutral 1
Pearson Correlation
Sig. (2-tailed)
Rx to neutral 2
Pearson Correlation
Sig. (2-tailed)
Rx to high intensity 1
Pearson Correlation
Sig. (2-tailed)
Rx to high intensity 2
Pearson Correlation
Sig. (2-tailed)
Note: 1 = pre; 2 = post; Rx = Reaction Time
*Correlation is significant at the .05 level (2-tailed)

SHAPS Score
-.44*
.03
-.37
.06
-.38
.06
-.49*
.01
-.30
.14
-.27
.18

Main effects of group membership and time remained non-significant at a
significance threshold of p = .05 when covariates were excluded (see Table 5).

ηp 2
.00
.12
.03
ηp 2
.22
.01
.08
.02
.19
.00
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However, there was a significant main effect of facial intensity (F(2, 48) = 21.41, p < .01,
ηp2 = .55). Consistent with what we expected, the participants, regardless of group,
reacted the slowest when asked to identify faces that elicited low intensity positive
emotions and responded the fastest to high intensity faces. Pairwise comparisons
among the three face types can be seen in Table 6. As shown in Figure 3.1,
participants’ reaction times to neutral faces were marginally faster than their reaction
speed to low intensity faces. The interaction between time and group membership was
also non-significant.
Table 5
Repeated-Measures ANOVA with Reaction Speed as the Dependent Variable
Tests of Within-Subjects Effects
Type III Sum
df
F
p
of Squares
Time
1002638.02
1
1.82
.19
Facial Intensity
9823864.74
2
21.41
<.01*
Time * Group
5526.00
1
.01
.92
Tests of Between-Subjects Effects
Type III Sum of
df
F
p
Squares
Intercept
340945398.00
1
314.08
.00
Group
2867968.81
1
2.64
.12
Error
26053151.20
24
*p < .05

ηp 2
.07
.55
.00
ηp 2
.93
.10

Table 6
Pairwise Comparisons Among Facial Intensities (Reaction Speed)
Pairwise Comparisons
Mean
Standard
Facial Intensity Mean (ms)
Comparison
Differences
Error
Low Intensity
1686.45 High Intensity
558.34
86.77
Neutral
52.76
65.73
Neutral
1633.69 Low Intensity
-52.76
65.73
High Intensity
505.58
86.38
High Intensity
1128.11 Low Intensity
-558.34
86.77
Neutral
-505.58
86.38
*p < .05

p
<.01*
.43
.43
<.01*
<.01*
<.01*
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Figure 3.1 Performances on Reaction Times Based on Group Membership and Intensity
of Facial Stimuli
3.2 Accuracy
Results of a repeated-measures one-way ANCOVA, with accuracy as the
dependent variable and number of medications, age, pre-treatment SHAPS scores,
MADRS scores, and gender included as covariates, indicated no statistically significant
main effects of treatment group, time, or face type. The interaction between time and
group membership was also non-significant. No other significant main effects or
interactions were observed (see Table 7).
Table 7
Repeated-Measures ANCOVA with Accuracy as the Dependent Variable
Tests of Within-Subjects Effects
Type III Sum
df
F
p
of Squares
Time
.89
1
.22
.64
Facial Intensity
89.12
1
2.77
.07

ηp 2
.01
.12
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Time * Group

Intercept
Gender
MADRS
Medications
SHAPS
Group
Error

1.30
1
.33
Tests of Between-Subjects Effects
Type III Sum
df
F
of Squares
672.211
1
59.29
25.19
1
2.22
1.19
1
.11
17.08
1
1.51
16.49
1
1.45
5.93
1
.52
226.76
20

.58

.02

p

ηp 2

.00
.15
.75
.23
.24
.48

.75
.10
.01
.07
.07
.03

Similarly, when a repeated-measures one-way ANOVA was conducted with the
exclusion of the covariates, results indicated no statistically significant main effects of
group or time; however, there was a significant difference in performance in the
accurate identification of different intensities of positive faces (F(1,24) = 309.65, p < .05,
ηp2 = .93) (See Table 8). All participants, regardless of group membership, were the
most accurate when asked to identify high intensity positive faces, and they performed
the worst when asked to accurately identify the faces eliciting low intensity positive
emotions (Figure 3.2). Table 9 shows pairwise contrasts that indicate significant
differences in accuracy across all facial comparisons. No other significant main effects
or interactions were observed. The interaction between time and group membership
was also non-significant.
Table 8
Repeated-Measures ANOVA with Accuracy as the Dependent Variable
Tests of Within-Subjects Effects
Type III Sum
df
F
p
of Squares
Time
5.34
1
1.29
.27
Facial Intensity
9889.00
1
309.65
<.01*
Time * Group
.95
1
.23
.64
Tests of Between-Subjects Effects

ηp 2
.05
.93
.01
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Intercept
Group
Error
*p < .05

Type III Sum of
Squares
68150.06
5.57
278.36

df

F

p

ηp 2

1
1
24

5875.95
.48

.00
.50

.99
.02

Table 9
Pairwise Comparisons Among Facial Intensities (Accuracy)
Pairwise Comparisons
Mean
Facial Type
Mean
Comparison
Differences
Low Intensity
12.95
High Intensity
-18.91
Neutral
-5.14
Neutral
18.08
Low Intensity
5.14
High Intensity
-13.78
High Intensity
31.86
Low Intensity
18.91
Neutral
13.78
* p < .01

Standard
Error
.59
1.10
1.10
.55
.59
.55

p
<.01*
<.01*
<.01*
<.01*
<.01*
<.01*

Figure 3.2 Performances on Accuracy Based on Group Membership and Intensity of
Facial Stimuli
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3.3 Exploratory Analysis
When SHAPS score was removed as a covariate, results of the initial analyses
did not change. The repeated-measures ANCOVA conducted with reaction time as the
dependent variable indicated no significant main effects of group, time, or facial intensity
(Table 10). However, as shown in Table 11, although the repeated-measures ANCOVA
with accuracy as the dependent variable indicated no significant main effects of group
membership or time, there was a significant main effect of facial intensity on the
participant’s ability to accurately respond (F(1,21) = 5.71, p = .01, ηp2 = .21). Similarly
as before, participants were the most accurate when asked to quickly identify positive
emotions in high intensity faces; however, they performed significantly worse when
asked to identify positive emotions in more ambiguous faces (e.g., low intensity, neutral
faces).Further, there were no significant time by group interactions on either reaction
time or accuracy.
Table 10
Repeated-Measures ANCOVA on Reaction Time (Without SHAPS)
Tests of Within-Subjects Effects
Type III Sum of
df
F
p
Squares
Time
367970.90
1
.64
.43
Facial Intensity
6251.02
2
.02
.98
Time * Group
165588.43
1
.29
.60
Tests of Between-Subjects Effects
Type III Sum of
df
F
p
Squares
Intercept
997266.03
1
.89
.36
Gender
1040687.38
1
.93
.35
MADRS
1165552.62
1
1.04
.32
Meds
108670.35
1
.10
.76
Group
888897.95
1
.79
.38
Error
23611167.40
21

ηp 2
.03
.00
.01
Partial Eta
Squared
.04
.04
.05
.01
.04
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Table 11
Repeated-Measures ANCOVA on Accuracy (Without SHAPS)
Tests of Within-Subjects Effects
Type III Sum of
df
F
p
Squares
Time
5.23
1
1.25
.28
Facial Intensity
182.17
1
5.71
.01*
Time * Group
.07
1
.02
.90
Tests of Between-Subjects Effects
Type III Sum of
df
F
p
Squares
Intercept
1485.29
1
128.23
< .01
Gender
16.84
1
1.45
.24
MADRS
2.34
1
.20
.66
Meds
7.57
1
.65
.43
Group
15.34
1
1.32
.26
Error
243.25
21

ηp 2
.06
.21
<.01
Partial Eta
Squared
.86
.07
.01
.03
.06

DISCUSSION
This study of the effects of rTMS treatment on how quickly and accurately adults
with MDD identified positive emotions in an array of faces extends previous research on
the utility of rTMS to combat symptoms of depression, particularly when it is
administered to the left DLPFC (Davidson, 2004; Taylor & Liberzon, 2007). Given
previous research on the beneficial effects of rTMS for acute depression, we
hypothesized that rTMS treatment would have an ameliorating effect on one
behaviorally-measured aspects of anhedonia. Specifically, we predicted that depressed
participants who underwent 20 active high frequency rTMS sessions would react faster
and more accurately in identifying positive emotions, especially low-intensity positive
faces, on the Happy Faces Task than would participants who underwent sham
treatment.
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We did not find any significant treatment effects on the participants’ ability to
quickly and accurately identify different facial intensities on the Happy Faces Task. Yet,
as predicted, we found that individual’s speed and accuracy varied as a function of
stimulus face emotional intensity. We had anticipated that depressed individuals would
more accurately identify faces that elicited low intensity positive emotions than faces
showing high intensity positive emotions. Results from the analyses were consistent
with this idea, and participants were significantly better at identifying faces that exhibited
evident positive emotions than more subtle faces that displayed more ambiguous
expressions (neutral and low intensity faces), suggesting that depressed individuals
may demonstrate difficulties in quickly deciphering between neutral faces and faces that
exhibit low levels of positive emotions.
Interestingly, we found a significant effect of SHAPS score on participants’ reaction
speed to the different facial stimuli, such that individuals who endorsed greater levels of
anhedonia were faster in identifying low intensity faces and neutral faces. This
observation deviated from our hypotheses, in which we assumed that more anhedonic
individuals would be slower in processing happiness in faces, especially faces eliciting
low intensity positive emotions. Subjective factors, such as alertness, level of attention
and focus, and impulsivity may have played a role in these findings. Although
depression-related anhedonia has been associated with reduced levels of arousal,
research focusing on attentional processes in individuals with anhedonia is sparse (Amr
& Volpe, 2013). However, given the small sample size and resulting low power of the
study, caution is warranted in interpreting this finding unless it is replicated. Future
studies focused on anhedonia and facial expression identification would benefit from
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recruiting larger samples and from including measures to assess subjective levels of
attention/alertness and impulsivity.
Overall, these findings indicate that although rTMS to the left DLPFC has been
shown to provide moderate general antidepressant effects for individuals with
depression, it may not induce changes in the behaviorally measured aspect of social
anhedonia presented here (i.e., identification of positive emotion in others’ faces).
Given that all patients were also taking psychoactive medications at the time of the
study (on a stable dose), it is possible that these patients may not have demonstrated a
measurable change in performance with active rTMS because symptoms were
dampened or relieved by concurrent psychoactive medication usage. Future studies
should better rule out this possibility by excluding participants that are medicated at the
time of the study or comparing medicated and unmedicated individuals.
Current neuroimaging models of depression suggest that disruptions in the
interactions among emotion-regulating regions such as the DLPFC, VLPFC,
dorsomedial prefrontal cortex (DMPFC), VMPFC, and the dorsal and ventral ACC
contribute to the onset of depressive symptoms (Seminowicz et al., 2004; Greicius et
al., 2007; Price & Drevets, 2012; Johnstone et al., 2007; Davey et al., 2012). Further,
researchers propose that different clinical subtypes and depression profiles based on
symptomatology may depend on underlying patterns of network disruption (Downar et
al., 2014). Multiple studies have postulated that dopamine (DA) pathway impairment—
with circuitry coursing through the ACC, amygdala, and the prefrontal cortex—
contributes to the prevalence of anhedonia (Martin-Soelch, 2009). In the
“endophenotype concept” model of MDD (Figure 4.1), Gorwood (2008) suggests that
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anhedonia is an intermediate endophenotype, defined as a heritable mechanism that
bridges the gap between clinical phenotypes and genetics, that results from a deficit in
reward processing, which can be influenced by either a genetic predisposition or the
presence of environmental risk factors (Gottesman, Hon, & Gould, 2003).
Other evidence suggests that hedonic processing is not a unitary construct but
rather consists of both anticipatory (motivation to pursue an impending reward) and
consummatory (in-the-moment aspects of pleasure) phases; reduced activations and
disruptions in brain areas that process either consummatory and/or anticipatory aspects
of reward processing (such as prefrontal subregions, thalamus, insula, and the ventral
striatum) can result in an anhedonic presentation (Sherdell et al., 2012; Höflich et al.,
2019). Nestler and Carlezon (2006) suggested that the mesolimbic dopamine system,
which is dependent on dopaminergic connections between subcortical areas of the
brain such as the NAcc and ventral tegmental area (VTA) of the midbrain, contribute to
the interpretation of reward and hedonic processing; disruptions of this system can also
result in anhedonia-like symptoms. The mesolimbic dopaminergic system also includes
projections from the VTA to the medial PFC, and a reduction or interruption of dopamine
release along this pathway can also result in amotivation and an anhedonic profile
(Drevets, Price & Furey, 2008).
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Figure 4.1. The role of anhedonia as an endophenotype between risk factors and
depression as proposed by Gorwood et al. (2008)
Downar et al. (2014) posited that different treatment modalities, whether invasive
or noninvasive, could be used to target specific brain regions that are involved within
these neural systems in order to intervene more efficaciously. Invasive techniques such
as high-frequency deep brain stimulation (DBS) of subcortical brain regions, such as the
subgenual cingulate gyrus and the NAcc, have been incorporated as an effective
technique for reducing depression-like symptoms in treatment-resistant depression
(Mayberg et al., 2005; Delaloye & Holtzheimer, 2014). With respect to noninvasive
techniques, current studies primarily use rTMS to reduce depressive symptoms.
However, given the current results, questions remain open regarding the efficacy of
rTMS treatment targeting the left DLPFC for adequately addressing the social aspect of
anhedonia measured in this study.
While the treatment of depression with active rTMS has consistently centered on
the DLPFC, emerging evidence suggests that other cortical brain regions may play a
central role in depression. For example, a neuroimaging study looking at the effects of
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rTMS found that the VMPFC, an area that is often linked with reward learning and
interpretation of rewards, acts as a “bottleneck” region in depressed patients with
anhedonia, who demonstrate poorer connectivity between areas of the mesolimbic
dopaminergic system (i.e. VTA and left caudate nucleus). This observation suggests
that VMPFC may be a potential future target for effective rTMS treatment of hedonic
processing (Downar et al., 2014). Another study found that abnormal VMPFC and
striatal activity was present in anhedonic populations when they responded to positive
stimuli; anhedonic participants who found it difficult to respond happily to positive stimuli
displayed a greater VMPFC response, which is the reverse of the pattern often
observed in healthy adults (Keedwell et al., 2005). The effects on anhedonic symptoms
of rTMS to the VMPFC region might thus be worthwhile to examine.
Another brain region in which to explore the utility of rTMS is the VLPFC, a
cortical area that has been shown to exhibit abnormal patterns of hyperactivity in
depressed individuals during positive affect inhibition. In one study, individuals who
were respondent to antidepressant medication and showed the greatest reduction in
anhedonia after 8 weeks of treatment exhibited lower levels of VLPFC activity when
asked to suppress positive affect (Light et al., 2011). Other studies found that
depressed patients exhibited greater activity in the VLPFC while processing positive
stimuli, which may result in the experience of excessive negative affect and an overall
reduction to experience pleasure and positive affect (Light et al., 2001; Keedwell et al.,
2005; Kumari et al., 2003). Given the role of VLPFC in hedonic processing and the
experience of positive affect, rTMS treatment targeting the suppression of activity in the
VLPFC in depressed individuals may be a potential alternative to pursue. Moreover,
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researchers could compare the effects of rTMS to the DLPFC and VMPFC on both selfreported and behaviorally measured anhedonia.
An important limitation of this study is that the sample sizes in both groups were
very small, which may have obscured significant relationships. It will be helpful for future
researchers to replicate this study using a larger sample, which will increase the study’s
power and increase the likelihood of detecting true relationships. Another limitation of
this study is the lack of racial diversity in the sample; there was only one Asian
participant in the sample, and the rest were Caucasian. Studies have shown that the
diagnosis and treatment of depression in both adult populations can be influenced by
racial and ethnic differences; this relationship is mediated by the presence of life factors
such as socioeconomic status, social support, and exposure to poverty that vary across
ethnic and racial groups (U.S. DHHS, 2001; Plant & Sachs-Ericsson, 2004; Holahan et
al., 1999). Thus, the presentation and severity of depression and anhedonia may
manifest differently as a function of racial and ethnic disparities (Dunlop et al., 2003;
Akincigil et al., 2012). Inclusion of participants from a variety racial/ethnic backgrounds
would be useful for evaluating the generalizability of rTMS treatment effects.
Of note, anhedonia can manifest in different ways and can include physical,
social, appetitive, and consummative features (Ho & Sommers, 2014). Whereas
physical anhedonia refers to decreases in ability to experience pleasure from physical
activities (i.e. eating, sex), social anhedonia refers to reduction in ability to experience
pleasure with loved ones and friends (Blanchard et al. 2011; Reise et al., 2011; Ho &
Sommers, 2014). Studies have found that individuals experiencing anhedonia can have
intact anticipatory pleasure and a deficit in consummatory pleasure, the reverse trend,
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or deficits in both (Martin et al., 2011; Strauss et al., 2011; Der-Avakian & Marou, 2012).
Thus, although the results of the study implied that rTMS treatment did not have any
beneficial effect on the depressed individuals’ facial processing skills, which may tap
aspects of consummatory and/or social pleasure, these results cannot decisively rule
out potential treatment effects to other facets of anhedonia, including physical or
anticipatory pleasure. Future studies might further explore the utility of rTMS to the left
DLPFC for treating other facets of anhedonia.
In conclusion, our results suggest that rTMS treatment to the left DLPFC in
depressed patients does not significantly improve speed of or accuracy in identifying
positive emotions in facial stimuli. Hedonic processing of positive stimuli in one’s
environment, whether personal or social, requires one to learn and assess its reward
value. Given that these skills are often compromised in anhedonic adults, future studies
might examine how rTMS modulation of activity in regions the brain—such as the
VMPFC—that support reward learning may reduce both anhedonic and more traditional
depressive symptoms.
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